Page last updated: 2024-09-04

gamma-glu-asp and 3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid

gamma-glu-asp has been researched along with 3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid in 1 studies

Compound Research Comparison

Studies
(gamma-glu-asp)
Trials
(gamma-glu-asp)
Recent Studies (post-2010)
(gamma-glu-asp)
Studies
(3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid)
Trials
(3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid)
Recent Studies (post-2010) (3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid)
210611724

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Destrade, C; Eichenlaub, D; Mélan, C; Messier, C; Ungerer, A1

Other Studies

1 other study(ies) available for gamma-glu-asp and 3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid

ArticleYear
Blockade of spontaneous posttraining performance improvement in mice by NMDA antagonists.
    Pharmacology, biochemistry, and behavior, 1997, Volume: 56, Issue:4

    Topics: Animals; Conditioning, Operant; Dipeptides; Excitatory Amino Acid Antagonists; Generalization, Psychological; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Piperazines; Receptors, N-Methyl-D-Aspartate; Retention, Psychology; Species Specificity

1997